Sectoral Asset Management Inc Agios Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $318,378 - $525,742	-9,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$34.45 - $53.48 $323,830 - $502,711	9,400 New	9,400 $503,000
Q1 2020 May 13, 2020	SELL	$31.52 - $53.81 $1.07 Million - $1.83 Million	-34,100 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$30.08 - $50.59 $339,904 - $571,667	-11,300 Reduced 24.89%	34,100 $1.63 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $1.12 Million - $1.72 Million	-34,600 Reduced 43.25%	45,400 $1.47 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $923,400 - $1.36 Million	20,000 Added 33.33%	80,000 $3.99 Million
Q1 2019 May 14, 2019	BUY	$45.92 - $67.67 $2.76 Million - $4.06 Million	60,000 New	60,000 $4.05 Million
Q4 2018 Feb 12, 2019	SELL	$42.73 - $76.53 $2.4 Million - $4.3 Million	-56,207 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $4.03 Million - $5.17 Million	56,207 New	56,207 $4.34 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $2.86 Million - $4.14 Million	-47,799 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $2.62 Million - $3.21 Million	47,799	47,799 $3.19 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.